📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells. (2024)

First Author: Lipreri Da Silva JC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejphar.2024.177161

PubMed Identifier: 39615869

Publication URI: http://europepmc.org/abstract/MED/39615869

Type: Journal Article/Review

Volume: 987

Parent Publication: European journal of pharmacology

ISSN: 0014-2999